CME Group Set to Report Q1 Earnings with Positive Outlook

Valued at $90.9 billion by market cap, CME Group Inc. (CME) stands as the world’s leading derivatives marketplace. Based in Chicago, this derivatives exchange provides a comprehensive range of global benchmark products across major asset classes. These include futures and options focused on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather, and real estate.

Upcoming Earnings Report

CME Group is set to release its first-quarter results on Wednesday, April 23, before markets open. Analysts anticipate that CME will report a non-GAAP profit of $2.64 per share, reflecting a significant 5.6% increase from the $2.50 reported in the same quarter last year. Notably, CME has exceeded Wall Street’s bottom-line projections for four consecutive quarters.

Fiscal 2025 Projections

For the full fiscal year 2025, CME is expected to post an adjusted EPS of $10.72, representing a 4.5% growth from the $10.26 reported in fiscal 2024. Furthermore, projections indicate earnings will rise 4.3% year-over-year to $11.18 per share for fiscal 2026.

Strong Stock Performance

CME’s stock has surged nearly 19.9% over the past 52-week period, significantly outperforming the Financial Select Sector SPDR Fund’s (XLF) 5.2% returns and the S&P 500 Index’s ($SPX) 4.2% decline during the same timeframe.

Fiscal 2024 Results Overview

After releasing fiscal 2024 results on February 12, CME’s stock rose nearly 3%. The company reported solid daily volumes throughout the year, achieving a 9.9% year-over-year increase in total revenues to a record $6.1 billion. Additionally, Q4 revenues of $1.5 billion exceeded market expectations by 1.3%. Shareholders saw robust earnings growth of 9.3% year-over-year, totaling $3.5 billion, with a net margin of 56.8%. Notably, its adjusted EPS of $2.52 for Q4 surpassed consensus estimates by 3.3%, reinforcing investor confidence.

Analyst Ratings and Recommendations

The consensus on CME Stock is cautiously bullish, with an overall “Moderate Buy” rating. Among the 19 analysts covering the stock, seven recommend a “Strong Buy,” one suggests a “Moderate Buy,” eight advocate a “Hold,” one proposes a “Moderate Sell,” and two issue a “Strong Sell” rating. Currently, the stock trades slightly below its mean price target of $260.89.

On the date of publication, Aditya Sarawgi did not hold (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article are solely for informational purposes. For more details, please view the Barchart Disclosure Policy here.

More news from Barchart

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.